Menlo Ventures
- 3
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Aug 2026
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy3
From company funding records- Series B · $280M · Aug 2026None
Melo
San Francisco, CA · Led a round · Series B · $280M · Aug 2026
- Series B · $112M · Jul 2021None
Shape Therapeutics
Seattle, Washington, United States · Led a round · Series B · $112M · Jul 2021
- Series C · $32.5M · Jun 2011None
Lumosity
San Francisco, California · Led a round · Series C · $32.5M · Jun 2011
Their companies, round by round
From company funding records- MeloSan Francisco, CA
Neurorehabilitation and assistive tech
- Aug 2026Series B · $280MLed
- Nov 2025Series A extension · $25M
- Sep 2023Seed · $610K
- Jun 2020Seed · $4.2M
- Mar 2020Accelerator
- Shape TherapeuticsSeattle, Washington, United States
- Jul 2026Grant
- Jul 2021Series B · $112MLed
- Nov 2019Series A · $35.5M
- Jan 2019Spinoff / Spinout
- LumositySan Francisco, California
Digital therapeutics
- Jun 2014Secondary Market
- Aug 2012Series D · $31.5M
- Jun 2011Series C · $32.5MLed
- Jun 2008Series A · $3.1M
- Jun 2007Angel · $400K
Rounds marked Led list Menlo Ventures as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Aug 2026
Melo · Series B $280MLead
- Jul 2021
Shape Therapeutics · Series B $112MLead
With Decheng Capital, Breton Capital Management, New Enterprise Associates, Cherubic Ventures, Mission BioCapital, CureDuchenne Ventures, Highbury Group, Sofinnova Investments, VZVC, Willett Advisors, 8VC, Breton Capital Ventures
- Jun 2011
Lumosity · Series C $32.5MLead